Esketamine With or Without Integration Therapy for Treatment-Resistant Depression

NCT07369102 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Treatment-resistant Depression (TRD)

Interventions

DRUG: Esketamine hydrochloride (intranasal)
BEHAVIORAL: Integration Therapy

Sponsor

University of Puerto Rico